ConductScience.org, home

Paper620404

A survey of the growth characteristics of and the host reactions to one hundred C3H/He mammary carcinomas.

Vaage J. Cancer Res, 1978. Cited by 40 papers, by iCite.

Cite this record

ConductScience Library. A survey of the growth characteristics of and the host reactions to one hundred C3H/He mammary carcinomas. Papers, record 620404. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/620404

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
A survey of the growth characteristics of and the host reactions to one hundred C3H/He mammary carcinomas.
PubMed
Journal
Cancer Res
PubMed
Year
1978
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
40
iCite
Relative citation ratio, by iCite
1.53
iCite
Revised in PubMed
2006-11-15
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Vaage JJ

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Mammary Neoplasms, ExperimentalMajor topic
Neoplasm TransplantationMajor topic
Animals
Female
Host vs Graft Reaction
Injections, Intravenous
Lung Neoplasms
Mice
Mice, Inbred C3H
Mice, Inbred Strains
Transplantation, Homologous

Source PubMed

Download CSV of topics

Cited by7

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 40 citations.

PMIDTitleJournalYearIn PapersSource
6352014Host resistance to metastasis from mouse mammary carcinomas.Cancer Metastasis Rev1983https://conductscience.org/library/papers/6352014PubMed
6293110Natural and induced immunity to mouse mammary tumors and the mammary tumor virus (MuMTV).Springer Semin Immunopathol1982https://conductscience.org/library/papers/6293110PubMed
6192904Intratumor immunologic heterogeneity.Cancer Metastasis Rev1982https://conductscience.org/library/papers/6192904PubMed
6085722Studies of mammary carcinoma metastasis in a mouse model system. I: Derivation and characterization of cells with different metastatic properties during tumour progression in vivo.Clin Exp Metastasis1984https://conductscience.org/library/papers/6085722PubMed
3902300Implications of tumor progression on clinical oncology.Clin Exp Metastasis1985https://conductscience.org/library/papers/3902300PubMed
2924453Loss of spontaneous metastasizing potential in mouse mammary tumors.Clin Exp Metastasis1989https://conductscience.org/library/papers/2924453PubMed
507195Properties of metastatic and nonmetastatic cloned subpopulations of an ultraviolet-light-induced murine fibrosarcoma of recent origin.Am J Pathol1979https://conductscience.org/library/papers/507195PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/620404

GET https://conductscience.org/api/papers/v1/620404/authors